IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJV11I2A38

Cholesterol crystals identified using optical coherence tomography and virtual histology intravascular ultrasound

Adam J. Brown1,2*, MD; Daniel R. Obaid1, MD, PhD; Nick E. J. West2, MD; Martin Goddard3, MD; Martin R. Bennett1, MD, PhD

The deposition and accumulation of lipid within the arterial wall leads to the development and progression of atherosclerotic plaques. Cholesterol crystals (CCs) are formed from these lipid pools and both augment the inflammatory response and promote plaque rupture, possibly through inducing mechanical instability. Accordingly, identification of these structures is important for plaque risk stratification.

Optical coherence tomography (OCT) and virtual histology intravascular ultrasound (VH-IVUS) are invasive imaging modalities that permit plaque characterisation. Validation studies using these techniques have demonstrated their reliability to identify plaque constituents, including lipid and calcification. CCs are thought to be identifiable on OCT as linear, high-backscattering structures within fibroatheroma. However, OCT validation studies on CCs are lacking and their appearance on VH-IVUS unknown.

Here we present co-registered OCT (C7 Dragonfly™; St. Jude Medical, St. Paul, MN, USA) and VH-IVUS (Eagle Eye® Gold; Volcano Corporation, Rancho Cordova, CA, USA) images obtained from a human coronary artery imaged ex vivo on a proprietary pressure-perfused imaging rig (Figure 1). Consistent with previous experience, CCs (Figure 1A, Figure 1B) were clearly identified by OCT as bright, high-backscattering structures located within a lipid-rich plaque (Figure 1C). In contrast, on co-registered IVUS imaging, CCs resulted in a region of echogenic reflectivity (Figure 1D), which led to them being characterised as dense calcium by VH-IVUS spectral analysis (Figure 1E).

Figure 1. Co-registered images demonstrating cholesterol crystals on both optical coherence tomography and virtual histology intravascular ultrasound. An advanced atherosclerotic coronary lesion visualised by histology (A and B) with evidence of cholesterol crystals (arrows), identified by optical coherence tomography (C), greyscale intravascular ultrasound (D) and virtual histology intravascular ultrasound (E).

These images suggest that OCT offers improved diagnostic plaque characterisation compared with VH-IVUS for identification of cholesterol crystals in plaques.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 11 Number 2
Jun 19, 2015
Volume 11 Number 2
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV16I5A66 Aug 28, 2020
Vulnerable plaque imaging – a clinical reality?
Johnson T and Joshi N
free

Preclinical research

10.4244/EIJ-D-20-00202 Aug 28, 2020
Detection of cholesterol crystals by optical coherence tomography
Jinnouchi H et al
free

State-of-the-Art

10.4244/EIJ-D-24-00387 Jul 21, 2025
Advances in coronary imaging of atherosclerotic plaques
Garcia-Garcia H et al
free

CLINICAL RESEARCH

10.4244/EIJ-D-16-00317 Jun 20, 2017
Limitations of OCT in identifying and quantifying lipid components: an in vivo comparison study with IVUS-NIRS
Di Vito L et al
free

Image – Interventional flashlight

10.4244/EIJ-D-19-00775 Apr 2, 2021
Correlation of near-infrared spectroscopy, optical coherence tomography and post-mortem histology for lipid detection
Zanchin C et al
free

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
Trending articles
94.75

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
76.8

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
63

Image – Interventional flashlight

10.4244/EIJ-D-22-00074 Jun 3, 2022
Transcatheter aortic valve repair for aortic regurgitation with the Cusper device
Feld Y et al
free
58.2

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
49.1

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
49.1

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
31.1

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved